TAP
61
-3
EIX
62
-4
HSY
38
-7
SYF
86
3
SJM
21
-3
ADSK
67
2
M
50
-3
SLB
42
3
IR
58
-2
AON
34
2
CLX
65
-4
AZO
58
-2
WYNN
32
2
PWR
67
5
A
41
-3
LB
9
-3
NTRS
35
-14
AMG
58
8
NOV
43
4
CTSH
56
4
TAP
61
-3
EIX
62
-4
HSY
38
-7
SYF
86
3
SJM
21
-3
ADSK
67
2
M
50
-3
SLB
42
3
IR
58
-2
AON
34
2
CLX
65
-4
AZO
58
-2
WYNN
32
2
PWR
67
5
A
41
-3
LB
9
-3
NTRS
35
-14
AMG
58
8
NOV
43
4
CTSH
56
4
Financhill
Back

Calidi Biotherapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Buy
52

CLDI
Calidi Biotherapeutics

Last Price:
1.84
Seasonality Move:
-23.28%
Sell
16

NBY
NovaBay Pharmaceuticals

Last Price:
0.56
Seasonality Move:
-8.54%
Buy
52
Calidi Biotherapeutics (CLDI) is a Buy

Is Calidi Biotherapeutics a Buy, Sell or Hold?

  • The current Calidi Biotherapeutics [CLDI] share price is $1.90. The Score for CLDI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CLDI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
16
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CLDI Stock Price Chart

What is Calidi Biotherapeutics's stock price today?

  • The Calidi Biotherapeutics share price today is $1.90
    The current trend is moderately bearish and CLDI is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

CLDI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 49.59 Sell
Chaikin Money Flow: -381698 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.72 - 2.42) Sell
Bollinger Bands (100): (1.03 - 1.91) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 32.51 Sell
Chaikin Money Flow: -111892 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.72) Sell
Bollinger Bands (100): (0.35 - 0.97) Sell

CLDI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.01 Sell
20-day SMA: 2.16 Sell
50-day SMA: 1.59 Buy
200-day SMA: 2.4 Sell
8-day EMA: 1.99 Sell
20-day EMA: 1.97 Sell
50-day EMA: 1.76 Buy
200-day EMA: 7.49 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.58 Sell
20-day SMA: 0.64 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2.04 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.62 Sell
50-day EMA: 0.68 Sell
200-day EMA: 5 Sell

Calidi Biotherapeutics Earnings Growth & CLDI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.72 per share, and an increase next year of $0.29 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Calidi Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):